This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
To the Editor.
Olanzapine (Zyprexa, Eli Lilly) is an atypical antipsychotic approved in 1996 for clinical use in Europe and the United States. There is no recommended pediatric dose for olanzapine or any information on its effect on children.
The mother of a 2½-year-old boy discovered that one or two of her 7.5 mg olanzapine tablets were missing. Within 1 hour the boy was found sleeping and difficult to arouse. Over the next several hours he intermittently awoke. During these times he refused to interact (kiss, speak, play, dance) with …
Individual Login
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
Log in through your institution
Purchase access
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.